🎗️ Oncology Papers

Scholarly works matching "oncology" in Crossref, sorted by the number of times other DOI-registered works cite them. Citation counts come from Crossref and are usually lower than Google Scholar figures.

575 top-cited papers indexed

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

David Dearnaley, Isabel Syndikus et al. (2016)

The Lancet Oncology

1.2K citesjournal articlePDF

Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing

Hira Rizvi, Francisco Sanchez-Vega et al. (2018)

Journal of Clinical Oncology

1.2K citesjournal articlePDF

TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non–Small-Cell Lung Cancer

Roy S. Herbst, Diane Prager et al. (2005)

Journal of Clinical Oncology

1.2K citesjournal articlePDF

Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme

James J. Vredenburgh, Annick Desjardins et al. (2007)

Journal of Clinical Oncology

1.2K citesjournal articlePDF

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study

Karim Fizazi, Howard I Scher et al. (2012)

The Lancet Oncology

1.2K citesjournal articlePDF

American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer

Al B. Benson, Deborah Schrag et al. (2004)

Journal of Clinical Oncology

1.2K citesjournal articlePDF

Current state of immunotherapy for glioblastoma

Michael Lim, Yuanxuan Xia et al. (2018)

Nature Reviews Clinical Oncology

1.2K citesjournal articlePDF

Treatment landscape of triple-negative breast cancer — expanded options, evolving needs

Giampaolo Bianchini, Carmine De Angelis et al. (2021)

Nature Reviews Clinical Oncology

1.3K citesjournal articlePDF

Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer

Mitsuru Sasako, Shinichi Sakuramoto et al. (2011)

Journal of Clinical Oncology

1.2K citesjournal articlePDF

The biology and role of CD44 in cancer progression: therapeutic implications

Chen Chen, Shujie Zhao et al. (2018)

Journal of Hematology & Oncology

1.2K citesjournal articlePDF

Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343

Kevin S. Hughes, Lauren A. Schnaper et al. (2013)

Journal of Clinical Oncology

1.2K citesjournal articlePDF

Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma

Thomas M. Habermann, Edie A. Weller et al. (2006)

Journal of Clinical Oncology

1.2K citesjournal articlePDF

Medulloblastoma Comprises Four Distinct Molecular Variants

Paul A. Northcott, Andrey Korshunov et al. (2011)

Journal of Clinical Oncology

1.2K citesjournal articlePDF

Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study

Corey J Langer, Shirish M Gadgeel et al. (2016)

The Lancet Oncology

1.2K citesjournal articlePDF

A Randomized Trial of Pelvic Radiation Therapy versus No Further Therapy in Selected Patients with Stage IB Carcinoma of the Cervix after Radical Hysterectomy and Pelvic Lymphadenectomy: A Gynecologic Oncology Group Study

Alexander Sedlis, Brian N. Bundy et al. (1999)

Gynecologic Oncology

1.2K citesjournal articlePDF